Ticker
KURACompany Name
KURA ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 122.86M | 147.53% | $ 83.28M |
3/31/2025 | $ 110.55M | 162.6% | $ 67.99M |
12/31/2024 | $ 133.84M | 248.4% | $ 53.88M |
9/30/2024 | $ -169.24M | 0% | $ 0 |
6/30/2024 | $ -154.84M | 0% | $ 0 |
3/31/2024 | $ -138.01M | 0% | $ 0 |
12/31/2023 | $ -124.99M | 0% | $ 0 |
9/30/2023 | $ -117.21M | 0% | $ 0 |
6/30/2023 | $ -109.55M | 0% | $ 0 |
3/31/2023 | $ -114.37M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for KURA ONCOLOGY INC is calculated as follows: FCF [ $ -67.35M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |